Bill > S3822

This bill, titled the "Break Up Big Medicine Act," aims to prohibit pharmacy benefit managers (PBMs), insurers, and prescription drug or medical device wholesalers from being owned by the same entity that owns or controls medical service providers, such as doctors' offices or pharmacies. The bill's findings highlight concerns about large, consolidated healthcare companies controlling multiple parts of the healthcare supply chain, leading to conflicts of interest where these companies might steer patients towards their own affiliated pharmacies or doctors, potentially increasing costs and reducing quality of care. To address this, the bill mandates that companies owning an insurer or PBM must divest any medical providers or management services organizations they own, and companies owning drug or device wholesalers must divest any medical providers or management services organizations. Enforcement will be handled by the Federal Trade Commission (FTC) and the Department of Justice (DOJ), with provisions for civil actions by government agencies and private citizens, including penalties for non-compliance and the possibility of treble damages for those harmed. The FTC is also tasked with reviewing and potentially blocking future actions that could recreate these conflicts of interest.

Justice

https://www.congress.gov/bill/119th-congress/senate-bill/3822/all-info